Skip to content

Evidence based evaluation of yihuohuatan Decoction in the treatment of stable chronic obstructive pulmonary disease

Evidence based evaluation of yihuohuatan Decoction in the treatment of stable chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2100005309
Enrollment
Unknown
Registered
2021-09-15
Start date
2022-01-01
Completion date
Unknown
Last updated
2023-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Test group:Yihuotan recipe

Sponsors

?????????
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: a. It conforms to the stable stage of COPD diagnosed by western medicine; b. It is consistent with the syndrome of qi deficiency, blood stasis and phlegm turbidity in traditional Chinese medicine; c. Between 40-80 years old; d. Sign informed consent.

Exclusion criteria

Exclusion criteria: a. Chronic cough and wheezing caused by tuberculosis, tumor, irritating gas allergy, asthma and other factors confirmed by examination; b. Complicated with serious primary diseases such as cardiovascular, liver, kidney and hematopoietic system; c. Chronic bronchitis complicated with severe cardiac insufficiency; d. Patients with abnormal behavior or mental illness; e. Allergic constitution; f. Failing to use drugs according to regulations, unable to judge the curative effect or incomplete data, which affects the judgment of curative effect or safety; g. Patients participating in other clinical trials

Design outcomes

Primary

MeasureTime frame
Pulmonary function;

Countries

China

Contacts

Public ContactMao Bing

????????

maobing@medmail.com.cn18980601724

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026